Haemonetics Automated Cell Processor ACP™ 215

País: Singapur

Idioma: inglés

Fuente: HSA (Health Sciences Authority)

Disponible desde:

Transmedic Pte Ltd

clase:

Class C medical device

Fabricado por:

Haemonetics Corporation

Área terapéutica:

Hematology

indicaciones terapéuticas:

The ACP 215 system can perform the following types of procedures: •Prepare collected red blood cell products with glycerol for freezing. •Deglycerolize thawed red blood cell products, removing extra cellular components, and re-suspend the red blood cells in an additive solution. •Wash red blood cell units stored in commonly used AC and additive solutions to remove plasma and extra cellular components. The ability to process-control the addition and removal of cryroprotectant solution as well as wash banked blood in a closed system significantly improves the safety and availability of blood products.

Resumen del producto:

Models: ACP215 - 02215-220-E, RBC De-Glycerol. Sets 325mL BMB - 00236-00, RBC De-Glycerol. / Cell Wash Sets - 00235-00/235, RBC Glycerolization Sets - 00225-00/225, Additive Solution Formula 3 (AS-3), 300 mL - 0462A-00, Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M1), Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M2), Glucose 0.2% Sodium Chloride 0.9% 2000 ml - TMIS0220GOO (SOL.FIS.2000M)

Fecha de autorización:

2010-07-28